Searched for
MOLNUPIRAVIR TRIAL NEWS
Anti-Covid drugs potent against Omicron, antibody therapies less effective: StudyThe lab tests also showed that some antibodies have entirely lost their ability to neutralise Omicron at realistic dosages. "The bottom lin...- Merck says no safety concerns observed in molnupiravir phase-3 trial, shared relevant data with DCGIMerck Sharp & Dohme (MSD) on Friday said its COVID antiviral molnupiravir has cut the risk of hospitalization or death in Phase 3 clinical ...
- Merck v Pfizer: here's how the two new COVID antiviral drugs work and will be usedUK approved molnupiravir, the COVID antiviral developed by Merck and Ridgeback Therapeutics. Now, Pfizer has released results from trials o...
- WHO seeks more data from Merck and Bharat BiotechWHO assistant director said that the organisation expects to receive clarifications from Bharat Biotech by the end of this week on its COVI...
- View: Why vaccines alone would not be enough to beat Covid-19Vaccines can’t change the course of the pandemic overnight, and may not be able to entirely stop the spread of the virus. It will take mont...
Load More